Latest Security News

ARC Funds Limited reported a solid $530 million in funds under management for its Term Deposit Shop platform, while strategically selling Ausbiz TV convertible notes and completing a $738,000 capital raise to bolster its balance sheet and fuel growth.

Diversified United Investment Limited (DUI) and Australian United Investment Company Limited (AUI) have agreed to merge, creating a $2.5 billion investment entity expected to deliver higher dividends and operational efficiencies.

Mach7 Technologies reports a positive operating cash flow in Q2 FY26, securing its first customer for the new Flamingo Architecture product and advancing key strategic initiatives.

Australian Strategic Materials reports a significant 75% jump in NdFeB alloy deliveries at its Korean Metals Plant and advances heavy rare earth production, while announcing a transformative acquisition offer from Energy Fuels Inc.

Carnaby Resources has reported a 10% increase in its Greater Duchess Copper Gold Project resource, completed full ownership of the JV, and is advancing its pre-feasibility study with strong cash backing and promising drill results.

Nexus Minerals Limited reports significant progress at its Wallbrook Gold Project with high-grade drill results across multiple prospects and advancing permitting for Crusader-Templar. The company is positioning Wallbrook as an emerging gold camp with promising growth potential.

Taiton Resources has completed drilling at its Challenger West project and is preparing to drill at the Highway project's Yogi prospect, backed by a $2 million capital raise and a key board appointment.

Orion Minerals reported a December 2025 quarter marked by significant cash outflows offset by fresh financing, including a major convertible loan and ongoing talks with Glencore for substantial project funding.

Enlitic, Inc. reported its strongest quarter yet with record contract wins totalling A$4.3 million, alongside a strategic capital raise and new cost-saving measures to fuel growth.

Amplia Therapeutics reports encouraging clinical progress for its pancreatic cancer drug narmafotinib, with a 35% confirmed response rate in the ACCENT trial and FDA support for dose optimisation. The company also uplisted to the US OTCQB market and secured a key patent extending protection to 2040.

Felix Gold has transitioned from exploration to development with a metallurgical breakthrough producing military-grade antimony and is advancing pilot plant operations and government funding applications to meet US military demand.

Lotus Resources reports steady progress at its Kayelekera uranium mine despite supply challenges, while its Letlhakane project shows promising metallurgical advances. The company targets full production and first shipments in the second quarter of 2026.